One in eight men will be diagnosed with prostate cancer in their lifetime.

Maybe you or someone you love has gone through this experience. Prostate cancer is the most common cancer in men after skin cancer, and the second leading cause of cancer death in men, after lung cancer.

Survival rates are greatly improved with early detection and before the cancer has spread to other parts of the body.

“MRI fusion biopsy capabilities will allow us to find 30% more prostate cancers on initial biopsy while it is still early and the cancer is contained within the prostate. This increases our chances for cure.” 
Dr. Matthew Ferroni, Mercy Medical Center Urology Clinic

You can help Mercy Medical Center reach its goal of becoming a Prostate Cancer Center of Excellence. This includes bringing the very best in early detection technology to the Hall-Perrine Cancer Center with MRI fusion biopsy.

This new technology is not only more accurate, but also reduces pain and the infection rate associated with more invasive screening options.

Your generous support helps raise the $150,000 needed to purchase the MRI fusion biopsy – the most advanced prostate screening technology available.

Give today and know that you are helping Mercy diagnose cancer sooner and more accurately. Your caring gift has the power to improve patient outcomes and save lives.

You make a difference at Mercy – thank you!